Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Coulter & Justus Financial Services LLC

Coulter & Justus Financial Services LLC decreased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 33.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 48,665 shares of the pharmacy operator’s stock after selling 24,033 shares during the period. Walgreens Boots Alliance makes up approximately 0.9% of Coulter & Justus Financial Services LLC’s investment portfolio, making the stock its 16th largest position. Coulter & Justus Financial Services LLC’s holdings in Walgreens Boots Alliance were worth $1,271,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of WBA. Highlander Capital Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at approximately $26,000. Venturi Wealth Management LLC boosted its position in shares of Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the period. EverSource Wealth Advisors LLC boosted its position in shares of Walgreens Boots Alliance by 308.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 845 shares during the period. Rocky Mountain Advisers LLC purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $30,000. Finally, Planned Solutions Inc. purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $34,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on WBA shares. SVB Leerink reduced their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a report on Monday, March 18th. TD Cowen reduced their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, April 3rd. Raymond James reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. Barclays started coverage on shares of Walgreens Boots Alliance in a report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 target price on the stock. Finally, Morgan Stanley reduced their target price on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a report on Monday, April 1st. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $24.36.

Walgreens Boots Alliance Stock Up 1.1 %

NASDAQ:WBA traded up $0.19 during midday trading on Thursday, hitting $17.53. 7,822,938 shares of the company were exchanged, compared to its average volume of 13,563,594. The company has a fifty day simple moving average of $19.75 and a 200 day simple moving average of $21.65. Walgreens Boots Alliance, Inc. has a fifty-two week low of $17.25 and a fifty-two week high of $33.33. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $15.12 billion, a PE ratio of -2.48, a price-to-earnings-growth ratio of 1.10 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. During the same period last year, the business earned $1.16 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 6.3% compared to the same quarter last year. As a group, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 5.70%. The ex-dividend date is Monday, May 20th. Walgreens Boots Alliance’s payout ratio is currently -14.29%.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction on Tuesday, April 2nd. The shares were bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction on Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the transaction, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Manmohan Mahajan bought 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the acquisition, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.